Read up on weight loss injection side effects and you'll meet two unhelpful extremes: brochure-speak that waves everything away as "mild and temporary", and forum threads that read like disaster diaries. The fair picture sits in between — and can be compared. Mounjaro (tirzepatide), Wegovy (semaglutide) and the new Wegovy pill (oral semaglutide) act on the same gut-hormone system, so they share most of a side-effect profile — but not all of it, and the edges are worth knowing before you commit. What follows is information, not medical advice: side effects are exactly where a prescriber earns their keep.
Why three different medicines cause the same complaints
All three treatments mimic gut hormones that reduce appetite and slow how quickly the stomach empties. That mechanism is the point — you feel full sooner and eat less — but it's also the source of the complaints: food sitting longer in a slower stomach produces nausea, and a recalibrating digestive system can swing towards constipation or diarrhoea. It also explains the most useful fact here: side effects cluster around dose increases, because each step up asks your gut to adjust again — which is why they all start low and climb slowly.
Weight-loss injection side effects compared: the table
| Mounjaro | Wegovy | Wegovy pill | |
|---|---|---|---|
| Most common | Nausea, diarrhoea, constipation, vomiting, tiredness | Nausea (~40% in trials), diarrhoea, vomiting, constipation, headache | Nausea, diarrhoea, constipation, vomiting, headache |
| Rare but serious | Pancreatitis (rare), gallstones, dehydration straining the kidneys, low blood sugar with insulin or a sulfonylurea | Pancreatitis (rare), gallstones, NAION (a rare eye condition), low blood sugar in type 2 diabetes | Pancreatitis (rare), gallstones, dehydration straining the kidneys, low blood sugar in type 2 diabetes |
| Not suitable | Pregnancy or planning pregnancy, under-18s, tirzepatide allergy; caution: past pancreatitis, severe gut disease, diabetic eye disease | Pregnancy or breastfeeding, type 1 diabetes, semaglutide allergy, MTC/MEN2 history (US labelling); caution: past pancreatitis, severe gut disease | Pregnancy or breastfeeding, under-18s, semaglutide allergy, MTC/MEN2 history; caution: past pancreatitis, severe gut disease |
| Dose ladder (the built-in control) | 2.5 → 15 mg weekly, at least 4 weeks per step | 0.25 → 2.4 mg weekly over ~16 weeks — the gentlest ramp | 1.5 → 25 mg daily over ~12 weeks |
Profiles as summarised in each medicine's listing in our dataset · trial figures are averages, not guarantees · live prices on the homepage tables.
The differences that actually matter
The headline is similarity: nausea, diarrhoea, constipation and vomiting lead all three lists. Only Wegovy's listing pins a number to it — nausea in roughly 4 in 10 trial participants — and the other two sit in similar territory. No trial has crowned a clearly gentler option — be suspicious of anyone who declares one "the mild choice".
The edges are where the profiles part company. The fifth common effect differs: Mounjaro lists tiredness, Wegovy and the pill list headache. Wegovy's serious-but-rare list carries something the others don't — NAION, a rare eye condition. Mounjaro and the pill both flag dehydration straining the kidneys, so fluids matter if vomiting or diarrhoea strikes. And low blood sugar is chiefly a concern alongside insulin or certain type 2 diabetes treatments — a screening question, not a general risk.
Gallstones appear on all three lists — losing weight quickly is itself a contributor, so this one comes with the territory rather than any brand. For how the medicines differ beyond safety, see our plain-English explainer.
Pick a provider who'll actually talk to you
When week three turns queasy, a tick-box subscription is cold comfort. The Weight Clinic — our recommended provider — runs a monthly video review with a clinician, so dose decisions get made with someone who knows your history. It stocks all three treatments (Mounjaro £160 for 4 weeks at 2.5 mg, Wegovy and the Wegovy pill from £115), refunds you if the prescriber declines, and code NEWME takes £35 off a first order.
Check your suitability at The Weight Clinic → Prescription-only medicines — the prescriber decides, and can say no. If declined, you get your money back.When side effects hit — and how the ladders manage them
Expect the rough patches in the first days to weeks after starting and after each dose increase. The ladders are the medicine's own answer: Mounjaro opens on a 2.5 mg run-in dose that exists purely to acclimatise you, Wegovy takes around 16 weeks to reach 2.4 mg, and the pill climbs to 25 mg over roughly three months.
The ladder is also negotiable: if a step is treating you badly, a prescriber can hold your dose longer before moving up, or step back down — tolerating the medicine matters more than racing to the top. Providers commonly suggest smaller meals, going easy on rich food, and drinking plenty during escalation weeks; one tracked provider, myBMI, even includes anti-nausea medication in its package.
Red flags: when it isn't just "settling in"
A short list deserves urgency rather than patience: severe, persistent stomach pain (pancreatitis, though rare, is serious), signs of significant dehydration, upper-right abdominal pain that could be gallstones, or any allergic reaction all need prompt medical attention. If you can't keep fluids down, contact your prescriber. And serious or not, report suspected side effects through the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk — it's how the UK's real-world safety picture gets built.
Should side effects decide which one you choose?
On their own, rarely. The profiles overlap so heavily that picking "the gentle one" off a list is mostly guesswork; your own history — the thing the prescriber screens for — matters far more than the brand. If a particular caution applies to you, raise it in the consultation.
What you can control is everything around the medicine: the ramp speed you ask for, the budget at the dose you'll stay on — Wegovy 2.4 mg from £174.99, the pill's 25 mg from £190, Mounjaro 15 mg from £288.99 per 4 weeks, mapped in our price comparison — and the support behind the pen. Our five-question framework puts those pieces in order, and the 2026 rankings show where each option lands overall.
Key takeaway: Mounjaro, Wegovy and the Wegovy pill share the same core side effects — nausea, diarrhoea, constipation and vomiting, worst around dose increases and usually easing as the body adjusts. The differences sit at the edges: tiredness versus headache, Wegovy's rare eye-condition listing, hydration warnings on Mounjaro and the pill. None is provably gentler — so buy good support and a patient dose ladder rather than hunting for a "mild" option that doesn't exist.
Buy the support, not just the pen
Every Weight Clinic treatment comes with a monthly clinician video review — the setting where side effects get flagged early. Next-day delivery with needles included, a refund if the prescriber declines you, and NEWME gives £35 off your first order.
Start your consultation at The Weight Clinic → Prescription-only medicines. Not suitable for everyone — a qualified prescriber makes the final call.Side-effect questions, answered plainly
Which weight-loss injection has the fewest side effects?
None can honestly claim the title. All three share the same core profile — nausea, diarrhoea, constipation and vomiting — because they work the same way. Wegovy's trials recorded nausea in roughly 4 in 10 people; the others sit in similar territory. Tolerability varies far more between individuals than between medicines, and a patient dose ladder does more to limit side effects than swapping brands.
Do weight-loss injection side effects go away?
For most people the gut effects are worst in the first weeks of each new dose and ease as the body adjusts — that's why all three treatments increase the dose gradually. If an effect persists or is hard to live with, tell your prescriber: they can hold your dose longer, or step back down.
What are the serious side effects to watch for?
All three list pancreatitis (rare) and gallstones. Mounjaro and the Wegovy pill also warn about dehydration straining the kidneys, and Wegovy's listing includes NAION, a rare eye condition. Low blood sugar is mainly a risk alongside insulin or certain type 2 diabetes medicines. Report any suspected side effect through the MHRA Yellow Card scheme.
Can I take anything for the nausea?
Ask your prescriber before adding any medicine. Providers commonly suggest smaller meals, avoiding rich food, and keeping fluids up during dose increases — one provider we track, myBMI, includes anti-nausea medication in its package. If nausea is severe or you can't keep fluids down, contact your prescriber rather than pushing through.
Who shouldn't use these treatments at all?
They aren't for use in pregnancy — or while breastfeeding for the semaglutide products — nor for under-18s or anyone allergic to the active ingredient. A history of pancreatitis or severe gut disease calls for caution. That screening is what the prescriber consultation is for, and a responsible provider will decline when a treatment isn't suitable.